IceCure Medical Ltd. (ICCM): יחס שווי פעילות לרווח לפני ריבית, מסים ופחת

IceCure Medical Ltd (ICCM) is implementing eco-friendly standards in the development of cryoablation devices, reducing energy consumption and plastic use. The business generates revenue through the supply of tumor freezing systems to oncology centers for minimally invasive treatment. The confirmed price history on the EV/EBITDA chart, which currently stands at 0.00, highlights the company's expansion in the surgical segment, where it is displacing competitors through technological superiority.

For the innovative brand IceCure Medical Ltd (ICCM), which develops ProSense cryoablation systems, business valuation analysis requires accounting for debt load through the historical EV/EBITDA multiple. This indicator compares the total enterprise value (market capitalization and debt) with operating profit before interest, taxes, depreciation, and amortization, allowing investors to determine the asset's real price and avoid overpaying for the stock amid inflationary pressures.